Cerebral Palsy Nervous System Diseases
Conditions
Interventions
1. Control Group:
Control participants will use the Nintendo Wii Fit for 30-minute sessions, 3 times a week, over a 12-week period. They will have free choice over which games they cho
Sponsors
Sussex Community NHS Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Inclusion criteria for questionnaire (phase one of study): 1.1. Parents of children with cerebral palsy of any level (ie GMFCS 1-5) 1.2. Child aged 5 to 16 years old 1.3. Under management of Sussex Community NHS Trust identified from local clinical database 2. Inclusion criteria for randomised, single blind, controlled study (phase two of study): 2.1. Ambulatory Bilateral and Unilateral CP 2.2. GMFCS types I and II e.g. able to walk without a walking aid 2.3. Ability to follow simple task instruction 2.4. All school ages -from 5 up to the age of 16; primary -5 to 11 years and secondary >11 – 16 years, (Upper limit of 16 to avoid timetabling variations at 6th form programmes) 2.5. Under management of Sussex Community NHS Trust, identified from local clinical database
Exclusion criteria
Exclusion criteria: 1. Exclusion criteria for questionnaire (phase one of study): 1.1. Child aged less than 5 or over 16 years old 2. Exclusion criteria for randomised, single blind, controlled study (phase two of study): 2.1. Children who are GMFCS III, IV, V 2.2. Child/Family unable to follow simple task instructions in English 2.3. Over the age of 16, outside of school age 2.4. Child with epilepsy who is photosensitive and has had a seizure within the last year 2.5. On anticonvulsant medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Gross Motor Function Measurement (GMFM) 2. Bruininks-Oseretsky test of motor proficiency (BOT-2) 3. Timed up and go test (TUG) 4. Goal Attainment Scale (GAS) 5. Strengths and Difficulties Questionnaire Measurements will be taken at baseline (week 1), midway (week 6), and exit of trial period (week 12). Measurements will be taken by blinded members of the trial team. | — |
Countries
United Kingdom
Contacts
Public ContactWilliam Farr
Outcome results
None listed